ACURX PHARMACEUTICALS, LLC

Organization

WHITE PLAINS, NY, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Use of ibezapolstat to promote microbiome health
- Patent number 12,036,225
- Issue date Jul 16, 2024
- Acurx Pharmaceuticals, Inc.
- Kevin Garey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA polymerase IIIC inhibitors and use thereof
- Patent number 11,001,592
- Issue date May 11, 2021
- Acurx Pharmaceuticals, LLC
- Xiang Y. Yu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA polymerase IIIC inhibitors and use thereof
- Patent number 10,836,772
- Issue date Nov 17, 2020
- Acurx Pharmaceuticals, LLC
- Xiang Y. Yu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA polymerase IIIC inhibitors and use thereof
- Patent number 10,723,741
- Issue date Jul 28, 2020
- Acurx Pharmaceuticals, LLC
- Xiang Y. Yu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Use of Ibezapolstat to Promote Microbiome Health
- Publication number 20240316058
- Publication date Sep 26, 2024
- Acurx Pharmaceuticals, Inc.
- Kevin GAREY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DNA Polymerase IIIC Inhibitors and Use Thereof
- Publication number 20230250102
- Publication date Aug 10, 2023
- Acurx Pharmaceuticals, LLC
- Xiang Y. YU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Ibezapolstat to Promote Microbiome Health
- Publication number 20220409625
- Publication date Dec 29, 2022
- Acurx Pharmaceuticals LLC
- Kevin GAREY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DNA Polymerase IIIC Inhibitors and Use Thereof
- Publication number 20220112195
- Publication date Apr 14, 2022
- Acurx Pharmaceuticals, LLC
- Xiang Y. YU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Deuterium-Substituted 7-Substituted-2-(Benzylamino)-6-Ozopurine Com...
- Publication number 20220024925
- Publication date Jan 27, 2022
- Acurx Pharmaceuticals LLC
- Xiang Y. YU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DNA Polymerase IIIC Inhibitors and Use Thereof
- Publication number 20200308179
- Publication date Oct 1, 2020
- Acurx Pharmaceuticals, LLC
- Xiang Y. YU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DNA Polymerase IIIC Inhibitors and Use Thereof
- Publication number 20200308180
- Publication date Oct 1, 2020
- Acurx Pharmaceuticals, LLC
- Xiang Y. YU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
90845250 - GPSS
- Serial number 90845250
- Registration number 7177022
- Filing date Jul 23, 2021
- Acurx Pharmaceuticals, Inc.
- 42 - Scientific and technological services and research and design relating thereto

ACURX PHARMACEUTICALS, LLC

Organization

Patents Grantslast 30 patents

Use of ibezapolstat to promote microbiome health

DNA polymerase IIIC inhibitors and use thereof

DNA polymerase IIIC inhibitors and use thereof

DNA polymerase IIIC inhibitors and use thereof

Patents Applicationslast 30 patents

Use of Ibezapolstat to Promote Microbiome Health

DNA Polymerase IIIC Inhibitors and Use Thereof

Use of Ibezapolstat to Promote Microbiome Health

DNA Polymerase IIIC Inhibitors and Use Thereof

Deuterium-Substituted 7-Substituted-2-(Benzylamino)-6-Ozopurine Com...

DNA Polymerase IIIC Inhibitors and Use Thereof

DNA Polymerase IIIC Inhibitors and Use Thereof

Trademarklast 30 trademarks

90845250 - GPSS